Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-10-2015 | Article

Polymorphisms in host genes encoding NOSII, C-reactive protein, and adhesion molecules thrombospondin and E-selectin are risk factors for Plasmodium falciparum malaria in India

Authors: K. Kanchan, S. S. Pati, S. Mohanty, S. K. Mishra, S. K. Sharma, S. Awasthi, V. Venkatesh, S. Habib, Indian Genome Variation Consortium

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2015

Abstract

Cytoadherence of Plasmodium falciparum-infected red blood cells (RBCs) in host microvasculature and complex regulation of the immune response are important contributors to the clinical outcome of disease. We tested the association of 23 single nucleotide polymorphisms (SNPs) and a microsatellite repeat in adhesion molecule genes THBS1 and ESEL, and immune regulatory molecule genes NOSII, CRP, and MBL2 with falciparum malaria in populations residing in a malaria-endemic and a non-endemic region of India. The THBS1 haplotype CCCCA (rs1478604, rs7170682, rs2664141, rs12912082, rs3743125) was a risk factor in the endemic region (relative risk = 3.78) and an ESEL SNP (rs5368, His468Tyr) associated with cerebral malaria (CM) [CM vs. non-cerebral malaria (NCM), odds ratio (OR) = 2.23, p = 0.03]. In the non-endemic region, an ESEL 3′UTR SNP (rs5359) associated with enhanced risk of disease (OR = 3.62, p = 1 × 10⁻⁴) and the CT genotype of the CRP promoter SNP (C/T/A) strongly associated with protection (severe vs. control, OR = 0.29, p = 6 × 10⁻⁵). Long repeat alleles of the NOSII promoter microsatellite (CCTTT)_n exhibited strong association with protection and the NOSII ATG haplotype (rs3729508, rs2297520, rs9282801) was strongly protective against severe malaria in both regions (endemic, severe vs. control, OR = 0.05, p = 0.0001; non-endemic, severe vs. control, OR = 0.3, p = 1 × 10⁻⁵). Our results suggest differential contribution of variants of the investigated genes in determining the outcome of malaria in Indian populations.

Sherman IW, Eda S, Winograd E (2003) Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect 5:897–909CrossRefPubMed

Rowe JA, Claessens A, Corrigan RA, Arman M (2009) Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med 11:e16CrossRefPubMedCentralPubMed

de Mendonça VR, Goncalves MS, Barral-Netto M (2012) The host genetic diversity in malaria infection. J Trop Med 2012:940616CrossRefPubMedCentralPubMed

Sinha S, Qidwai T, Kanchan K, Anand P, Jha GN, Pati SS, Mohanty S, Mishra SK, Tyagi PK, Sharma SK; Indian Genome Variation Consortium, Venkatesh V, Habib S (2008) Variations in host genes encoding adhesion molecules and susceptibility to falciparum malaria in India. Malar J 7:250CrossRefPubMedCentralPubMed

Rock EP, Roth EF Jr, Rojas-Corona RR, Sherwood JA, Nagel RL, Howard RJ, Kaul DK (1988) Thrombospondin mediates the cytoadherence of Plasmodium falciparum-infected red cells to vascular endothelium in shear flow conditions. Blood 71:71–75PubMed

Zwicker JI, Peyvandi F, Palla R, Lombardi R, Canciani MT, Cairo A, Ardissino D, Bernardinelli L, Bauer KA, Lawler J, Mannucci P (2006) The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size. Blood 108:1280–1283CrossRefPubMedCentralPubMed

Gearing AJ, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ (1992) Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci 667:324–331CrossRefPubMed

Hviid L, Kurtzhals JA, Adabayeri V, Loizon S, Kemp K, Goka BQ, Lim A, Mercereau-Puijalon O, Akanmori BD, Behr C (2001) Perturbation and proinflammatory type activation of γδ1⁺ γδ T cells in African children with Plasmodium falciparum malaria. Infect Immun 69:3190–3196CrossRefPubMedCentralPubMed

Amodu OK, Gbadegesin RA, Ralph SA, Adeyemo AA, Brenchley PE, Ayoola OO, Orimadegun AE, Akinsola AK, Olumese PE, Omotade OO (2005) Plasmodium falciparum malaria in south-west Nigerian children: is the polymorphism of ICAM-1 and E-selectin genes contributing to the clinical severity of malaria? Acta Trop 95:248–255CrossRefPubMed

10.

Moncada S (1997) Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci 811:60–67, discussion 67–69CrossRefPubMed

11.

Taylor-Robinson AW, Phillips RS, Severn A, Moncada S, Liew FY (1993) The role of TH1 and TH2 cells in a rodent malaria infection. Science 260:1931–1934CrossRefPubMed

12.

Weinberg JB, Lopansri BK, Mwaikambo E, Granger DL (2008) Arginine, nitric oxide, carbon monoxide, and endothelial function in severe malaria. Curr Opin Infect Dis 21:468–475CrossRefPubMedCentralPubMed

13.

Levesque MC, Hobbs MR, O’Loughlin CW, Chancellor JA, Chen Y, Tkachuk AN, Booth J, Patch KB, Allgood S, Pole AR, Fernandez CA, Mwaikambo ED, Mutabingwa TK, Fried M, Sorensen B, Duffy PE, Granger DL, Anstey NM, Weinberg JB (2010) Malaria severity and human nitric oxide synthase type 2 (NOS2) promoter haplotypes. Hum Genet 127:163–182CrossRefPubMedCentralPubMed

14.

Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, Mwaikambo ED, Lal AL, Granger DL, Anstey NM, Weinberg JB (2002) A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360:1468–1475CrossRefPubMed

15.

Burgner D, Xu W, Rockett K, Gravenor M, Charles IG, Hill AV, Kwiatkowski D (1998) Inducible nitric oxide synthase polymorphism and fatal cerebral malaria. Lancet 352:1193–1194CrossRefPubMed

16.

Jack DL, Turner MW (2003) Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 31:753–757CrossRefPubMed

17.

Thévenon AD, Leke RG, Suguitan AL Jr, Zhou JA, Taylor DW (2009) Genetic polymorphisms of mannose-binding lectin do not influence placental malaria but are associated with preterm deliveries. Infect Immun 77:1483–1491CrossRefPubMedCentralPubMed

18.

Garred P, Nielsen MA, Kurtzhals JA, Malhotra R, Madsen HO, Goka BQ, Akanmori BD, Sim RB, Hviid L (2003) Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun 71:5245–5253CrossRefPubMedCentralPubMed

19.

Larsen F, Madsen HO, Sim RB, Koch C, Garred P (2004) Disease-associated mutations in human mannose-binding lectin compromise oligomerization and activity of the final protein. J Biol Chem 279:21302–21311CrossRefPubMed

20.

Nahrevanian H, Gholizadeh J, Farahmand M, Assmar M (2008) Patterns of co-association of C-reactive protein and nitric oxide in malaria in endemic areas of Iran. Mem Inst Oswaldo Cruz 103:39–44CrossRefPubMed

21.

Imrie H, Fowkes FJ, Michon P, Tavul L, Reeder JC, Day KP (2007) Low prevalence of an acute phase response in asymptomatic children from a malaria-endemic area of Papua New Guinea. Am J Trop Med Hyg 76:280–284PubMed

22.

Pied S, Nussler A, Pontent M, Miltgen F, Matile H, Lambert PH, Mazier D (1989) C-reactive protein protects against preerythrocytic stages of malaria. Infect Immun 57:278–282PubMedCentralPubMed

23.

Israelsson E, Ekström M, Nasr A, Dolo A, Kearsley S, Arambepola G, Homann MV, Maiga B, Doumbo OK, Elghazali G, Giha HA, Troye-Blomberg M, Berzins K, Tornvall P (2009) Marked differences in CRP genotype frequencies between the Fulani and sympatric ethnic groups in Africa. Malar J 8:136CrossRefPubMedCentralPubMed

24.

Giha HA, Nasr A, Ekström M, Israelsson E, Arambepola G, Arnot D, Theander TG, Troye-Blomberg M, Berzins K, Tornvall P, ElGhazali G (2010) Association of a single nucleotide polymorphism in the C-reactive protein gene (−286) with susceptibility to Plasmodium falciparum malaria. Mol Med 16:27–33CrossRefPubMedCentralPubMed

25.

Jha P, Sinha S, Kanchan K, Qidwai T, Narang A, Singh PK, Pati SS, Mohanty S, Mishra SK, Sharma SK, Awasthi S, Venkatesh V, Jain S, Basu A, Xu S; Indian Genome Variation Consortium, Mukerji M, Habib S (2012) Deletion of the APOBEC3B gene strongly impacts susceptibility to falciparum malaria. Infect Genet Evol 12:142–148CrossRefPubMed

26.

Indian Genome Variation Consortium (2008) Genetic landscape of the people of India: a canvas for disease gene exploration. J Genet 87:3–20CrossRef

27.

Kanchan K, Jha P, Pati SS, Mohanty S, Mishra SK, Sharma SK, Awasthi S, Venkatesh V, Habib S (2015) Interferon-gamma (IFNG) microsatellite repeat and single nucleotide polymorphism haplotypes of IFN-alpha receptor (IFNAR1) associated with enhanced malaria susceptibility in Indian populations. Infect Genet Evol 29:6–14CrossRefPubMed

28.

World Health Organization (WHO) (2000) Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94(Suppl 1):S1–S90CrossRef

29.

Gómez LM, Anaya JM, Vilchez JR, Cadena J, Hinojosa R, Vélez L, Lopez-Nevot MA, Martín J (2007) A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis (Edinb) 87:288–294CrossRef

30.

Nei M, Chesser RK (1983) Estimation of fixation indices and gene diversities. Ann Hum Genet 47:253–259CrossRefPubMed

31.

Holmberg V, Schuster F, Dietz E, Sagarriga Visconti JC, Anemana SD, Bienzle U, Mockenhaupt FP (2008) Mannose-binding lectin variant associated with severe malaria in young African children. Microbes Infect 10:342–348CrossRefPubMed

32.

Boldt AB, Luty A, Grobusch MP, Dietz K, Dzeing A, Kombila M, Kremsner PG, Kun JF (2006) Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun 7:393–400CrossRefPubMed

33.

Luty AJ, Kun JF, Kremsner PG (1998) Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. J Infect Dis 178:1221–1224CrossRefPubMed

34.

Wang Z, Liu Y, Liu J, Liu K, Lou Y, Wen J, Niu Q, Wen S, Wu Z (2010) E-selectin gene polymorphisms are associated with essential hypertension: a case–control pilot study in a Chinese population. BMC Med Genet 11:127CrossRefPubMedCentralPubMed

35.

Takei T, Iida A, Nitta K, Tanaka T, Ohnishi Y, Yamada R, Maeda S, Tsunoda T, Takeoka S, Ito K, Honda K, Uchida K, Tsuchiya K, Suzuki Y, Fujioka T, Ujiie T, Nagane Y, Miyano S, Narita I, Gejyo F, Nihei H, Nakamura Y (2002) Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum Genet 70:781–786CrossRefPubMedCentralPubMed

36.

Ohashi J, Naka I, Patarapotikul J, Hananantachai H, Looareesuwan S, Tokunaga K (2002) Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand. J Infect Dis 186:578–581CrossRefPubMed

37.

Kun JF, Mordmüller B, Perkins DJ, May J, Mercereau-Puijalon O, Alpers M, Weinberg JB, Kremsner PG (2001) Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria. J Infect Dis 184:330–336CrossRefPubMed

38.

Dhangadamajhi G, Mohapatra BN, Kar SK, Ranjit MR (2009) The CCTTT pentanucleotide microsatellite in iNOS promoter influences the clinical outcome in P. falciparum infection. Parasitol Res 104:1315–1320CrossRefPubMed

39.

Warpeha KM, Xu W, Liu L, Charles IG, Patterson CC, Ah-Fat F, Harding S, Hart PM, Chakravarthy U, Hughes AE (1999) Genotyping and functional analysis of a polymorphic (CCTTT)(n) repeat of NOS2A in diabetic retinopathy. FASEB J 13:1825–1832PubMed

40.

Seguin MC, Klotz FW, Schneider I, Weir JP, Goodbary M, Slayter M, Raney JJ, Aniagolu JU, Green SJ (1994) Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J Exp Med 180:353–358CrossRefPubMed

Title: Polymorphisms in host genes encoding NOSII, C-reactive protein, and adhesion molecules thrombospondin and E-selectin are risk factors for Plasmodium falciparum malaria in India
Authors: K. Kanchan
S. S. Pati
S. Mohanty
S. K. Mishra
S. K. Sharma
S. Awasthi
V. Venkatesh
S. Habib
Indian Genome Variation Consortium
Publication date: 01-10-2015
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2015
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-015-2448-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2015

Relevance of biofilm formation and virulence of different species of coagulase-negative staphylococci to public health

Target site antimicrobial activity of colistin might be misestimated if tested in conventional growth media

Direct identification of major Gram-negative pathogens in respiratory specimens by respiFISH® HAP Gram (−) Panel, a beacon-based FISH methodology

Dientamoeba fragilis prevalence coincides with gastrointestinal symptoms in children less than 11 years old in Sweden

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin

Ultrasound diagnosis of Clostridium difficile-associated diarrhea

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials